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(57) ABSTRACT
The present disclosure relates to a composition including an
extract from an Acidithiobacillus bacteria or a yeast
extracted after exposure of the bacteria to UV radiation. The
disclosure further relates to a method of preparing a UV-
blocking composition by exposing a culture of Acidithioba-
cillus or yeast to UV radiation and extracting UV-blocking
cellular material produced in response to the UV radiation
from the Acidithiobacillus or yeast. The disclosure further
relates to a method of protecting an item from UV radiation
damage by extracting UV-blocking cellular material from
Acidithiobacillus or yeast exposed to UV radiation and
covering the item with the UV-blocking cellular material.
The disclosure further relates to a UV-resistant yeast cell and
a UV-resistant bacterial cell.
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UV-RESISTANT MICROBES AND
UV-BLOCKING MICROBIAL EXTRACT
PRIORITY CLAIM
The present application is a continuation of pending U.S.
patent application Ser. No. 15/406,167 filed Jan. 13, 2017;
which is a continuation of U.S. patent application Ser. No.
14/105,543 filed Dec. 13, 2013, now abandoned; which
claims priority under 35. U.S.C. § 119 to U.S. Provisional
Patent Application Ser. No. 61/738,117, filed Dec. 17, 2012,
the contents of which are incorporate by reference herein in
their entirety.
STATEMENT OF GOVERNMENT INTEREST
Portions of the current invention were developed using
US government funding provided under NASA-NAG
9-1241 and SynBERC-NSF-University of California-Berke-
ley-1385638, and by the USDA under Evans-Allen-Prairie
View grant 2011-33100-8916. Accordingly, the US govern-
ment has certain rights in the invention. The invention
described herein was also made by an employee of the
United States Government and may be manufactured and
used by or for the Government of the United States of
America for governmental purposes without the payment of
any royalties thereon or therefor.
REFERENCE TO SEQUENCE LISTING
SUBMITTED VIA EFS-WEB
This application includes an electronically submitted
sequence listing in .txt format. The .txt file contains a
sequence listing entitled "2017-04-27
017575.1578_ST25.txt" created on Apr. 27, 2017 and is
5,996 bytes in size. The sequence listing contained in this
.txt file is part of the specification and is hereby incorporated
by reference herein in its entirety.
TECHNICAL FIELD
The present disclosure relates to engineered microbes,
such as bacteria and yeast, that are resistant to ultraviolet
(UV) radiation damage. The present disclosure also relates
to UV-protective microbial extracts that may be prepared
from such engineered microbes or from microbes exposed to
UV radiation. The disclosure further relates to methods
using these microbes or extracts, such as fermentation
processes and methods of protecting agricultural plants or
other materials from UV radiation.
BACKGROUND
Exposure to UV radiation causes harmful effects in a wide
variety of things, both living and non-living. For example,
exposure of human skin to UV radiation can cause sever
sunburn and skin cancer and exposure of beneficial micro-
organisms to UV radiation can kill them. UV radiation can
also cause materials to degrade prematurely and thus suffer
mechanical failure or otherwise become unable to serve their
intended purpose.
The harmful effects of UV radiation can generally be
prevented to lessened through the simple step of absorbing
all or a portion of UV radiation before it reaches the thing
it may harm. For, example, chemicals in sunscreen absorb a
2
portion of the UV radiation that would normally reach the
skin and, as a result, help protect the skin from sunburn and
skin cancer.
Although numerous substances able to absorb UV radia-
5 tion are known, not all of them are suitable for all possible
uses. Further, some substances may be expensive to produce
or may have harmful side effects, such as toxicity or
undesired chemical reactions with a protected material.
Other substances simply do not last long enough in the
10 environment in which they are used or last too long.
Accordingly, there is a demand for new substances able to
absorb UV radiation, particularly if those substances are
biocompatible.
15 SUMMARY
The present disclosure relates to a composition including
an extract from an Acidithiobacillus bacteria or a yeast
extracted after exposure of the bacteria to UV radiation.
20 The disclosure further relates to a method of preparing a
UV-blocking composition by exposing a culture of Acidith-
iobacillus or yeast to UV radiation and extracting UV-
blocking cellular material produced in response to the UV
radiation from the Acidithiobacillus or yeast.
25 The disclosure further relates to a method of protecting an
item from UV radiation damage by extracting UV-blocking
cellular material from Acidithiobacillus or yeast exposed to
UV radiation and covering the item with the UV-blocking
cellular material.
30 The disclosure further relates to a UV-resistant yeast cell
including a plasmid comprising a nucleic acid encoding at
least one of a Msn4pn, a ruvB, a heat shock protein, an
alcohol dehydrogenase (ADH) protein, a NADH-cy-
tochrome b5 reductase 2, a NADP-specific glutamate dehy-
35 drogenase, a superoxide dismutase, a hexokinase protein, or
a phosphate glycerate mutase under control of a constitutive
or inducible promoter.
The disclosure further relates to a UV-resistant bacterial
cell including a plasmid comprising a nucleic acid encoding
40 at least one of a major outer membrane protein, a RuBisCO
large subunit 1 or 2, a phosphoribulokinase, a Ketol-acid
reductoisomerase, a pyridine nucleotide-disulfide oxoreduc-
tase, a methionine synthase, or a methyltransferase under
control of a constitutive or inducible promoter.
45
BRIEF DESCRIPTION OF THE DRAWINGS
Embodiments of the present invention may be better
understood through reference to the following figures in
50 which:
FIG. 1 illustrates a plasmid that may be used to produce
and located in a UV-resistant yeast.
DETAILED DESCRIPTION
55
The present disclosure relates to engineered microbes,
such as bacteria and yeast, that are resistant to ultraviolet
(UV) radiation damage. The present disclosure also relates
to UV-protective microbial extracts that may be prepared
60 from such engineered microbes or from microbes exposed to
UV radiation. The disclosure further relates to methods
using these microbes or extracts, such as fermentation
processes and methods of protecting agricultural plants or
other materials from UV radiation.
65 UV-Protective Extracts
UV-protective microbial extracts of the present disclosure
may be able to wholly or partially block the passage of UV
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radiation. The extent to which UV-radiation is blocked may
depend on a variety of factors including the microbial
source, the amount of extract applied, and the formulation of
the extracts.
The UV-protective extract may be prepared by exposing 5
a microbe culture, such as a bacteria or yeast culture, to UV
radiation, then extracting components from the culture via
centrifugation. The UV radiation may be of any wavelength,
but in specific embodiments it may be short wave (254 mu),
10long wave (365 mu), or a combination of both. In one 
embodiment, a bacterial extract may be derived from Aci-
dithiobacillus, particularly A. ferroxidans, after exposure of
bacteria culture to UV radiation, foe example for at least 72
hours. In another embodiment, a yeast extract may be 15
derived from S. cerevisiae or other yeast after exposure of
yeast culture to UV radiation, for example for at least 48
hours. In still another embodiment, the extract may be
prepared by culturing an engineered UV-resistant bacteria or
yeast, such as a bacteria or yeast of the type described below, 20
then extracting components from the culture via centrifuga-
tion.
According to one embodiment, extracts of the present
disclosure may be prepared by culturing an Acidithiobacil-
lus, such as A. ferroxidans or by culturing S. cerevisiae or 25
other yeast. Culture may proceed until dense, but not so
dense as to trigger deleterious responses such as those
triggered by lack of a food source. The culture may also not
be so dense as to prevent UV radiation from reaching a
substantial portion of bacteria or yeast in the culture. The 30
culture may then be irradiated with UV radiation. Prior to
irradiation, the culture may be transferred to one or move
vessels designed to allow a substantial portion of the bac-
teria or yeast to be irradiated. The wavelength of UV
radiation may be any wavelength, but in particular embodi- 35
ments may be selected to induce a radiation response in the
bacteria or yeast. Similarly, the length of exposure to the UV
radiation may be any length from the minimal amount
needed to induce a radiation response in at least some
bacteria or yeast of the culture up to a length of time at which 40
a substantial portion of the bacteria or yeast in the culture are
fatally irradiated.
After irradiation, the bacteria or yeast may continue to be
cultured for a time at least sufficient to allow some radiation
response in the bacteria or yeast. If the bacteria or yeast were 45
irradiated in a manner that causes death of a substantial
portion of the bacteria or yeast, culture may cease after the
majority of this bacterial or yeast death has occurred.
Alternatively, if the bacteria or yeast were not irradiated in
such a manner as to cause death of a substantial portion of 50
the bacteria or yeast, culture may continue until such time as
the radiation response has ceased in a substantial portion of
the bacteria or yeast.
Radiation response may include may include up-regula-
tion in a yeast of at least one of the following: a Msn4pn, a 55
ruvB, a heat shock protein, such as a heat shock protein
SSB1, an alcohol dehydrogenase (ADH) protein, a NADH-
cytochrome b5 reductase 2, a NADP-specific glutamate
dehydrogenase, a superoxide dismutase, a hexokinase pro-
tein, such as hexokinase 1, or a phosphate glycerate mutase. 60
Radiation response may include may include up-regulation
in a bacterium of at least one of the following: a major outer
membrane protein, such as major outer membrane protein
40, a RuBisCO large subunit 1 or 2, a phosphoribulokinase,
a Ketol-acid reductoisomerase, a pyridine nucleotide-disul- 65
fide oxoreductase, a methionine synthase, a hydromethyl-
transferase, a ribosomal protein s2, or a methyltransferase.
4
Radiation response may additionally or alternatively include
down-regulation in a yeast of at least one of the following:
a protein disulfide isomerase, an alpha-glucosidase MAL12,
a methyl tetrahydropteroyl triglutamate, a fructose-bispho-
sphate aldolase, or a glucokinase 1. Radiation response may
additionally or alternatively include down-regulation in a
bacterium of at least one of the following: a Hsp 20, a
caperonin, chaperone protein Dnak, or a Hsp 70.
It will be understood that up-regulation or down-regula-
tion of one or more of these proteins may not be directly
responsible for UV-protective properties, such that increased
or decreased amounts of these proteins in the extract may
have little or no effect on its UV-protective properties.
Rather, up-regulation or down-regulation of one of these
proteins may have downstream effects that ultimately pro-
duce a UV-protective extract.
The extract may be prepared in manner able to isolate at
least one UV-protective component. In particular embodi-
ments, the extract may include centrifuged bacterial com-
ponents. The extract may be formulated at a variety of
concentrations in any acceptable carrier to allow its use for
a particular purpose. In particular embodiments, the extract
may be formulated in an evaporable carrier, such as water or
alcohol, to allow the extract to dry on the surface of the
material to be protected from UV radiation.
In one example, the extract may be prepared by centri-
fuging the bacteria or yeast culture in a manner able to
precipitate most proteins, then discarding the supernatant
while retaining the pellet as the extract. The pellet may then
be used as is or dried. The pelleted material may be diluted
to a given concentration using any acceptable carrier, such
as water or alcohol. The carrier may be non-denaturing. The
carrier may also include materials to inhibit further bacterial
growth and/or protein degradation.
In an alternative example, the bacteria or yeast may not be
pelletized but may instead be killed, for example by lysis or
exposure to lethal levels of UV radiation, and the bacterial
or yeast culture medium may be used as is or in an
evaporated form. In this example materials to inhibit further
bacterial or yeast growth and/or protein degradation may
also be introduced.
In a further embodiment, isolated proteins from the bac-
teria or yeast culture may be used in place of a more general
extract to produce the UV-protective effect. Such proteins
may be isolated by further chemical extraction.
Use of UV-Protective Extract
The extract may be applied to any material that may
benefit from a reduction in UV radiation. The exact formu-
lation of the extract plus any carriers may be adjusted based
on the desired use. For example, the extract may be formu-
lated with only non-toxic components if it is to be used on
a human or animal or with another microorganism, such as
in a fermentation process or on an agricultural product. The
extract may be mixed with other substances provide UV-
protective properties to the overall composition. Further, if
coated on the material to be protected, the extract may itself
be covered with a further protective coating to protect, for
example, against mechanical wear and damage.
The extract may be formulated or applied in such a
manner as to block approximately 50%, 60%, 70%, 80%,
90%, 95%, or 99% of the UV radiation that encounters the
extract. The extract may also be formulated to block these
percentages of particular UV wavelengths, or, more gener-
ally, to block these percentages of longwave UV radiation or
shortwave UV radiation.
US 9,987,219 B2
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Extracts according to the present disclosure may be used
for a variety of purposes. These purposes include, but are not
limited to the following:
1) blocking UV radiation or other types of radiation;
2) protecting human skin against damage and/or skin
cancer induced by UV radiation or other types of
radiation;
3) protecting against side-effects of radiation used in
cancer treatments;
4) protecting animals from deleterious effects of UV
radiation or other radiation;
5) protecting plastic, glass, or other solid surfaces from
UV radiation or other radiation;
6) providing a UV radiation screen or screen for other
types of radiation;
7) protecting astronauts and/or other persons or organisms
as well as equipment during space trips;
8) enhancement of industrial fermentation processes or
other processes requiring energy by allowing the use of
UV radiation in connection with the process to supply
additional energy and thus to increase the ultimate
energy-requiring output of the cells, such as alcohol or
a drug, without substantially killing the fermenting
organism;
9) protection of experimentation, fermentation, biochemi-
cal, and/or biological processes under the presence of
UV radiation, for example in extraterrestrial conditions
such as on the Moon or Mars; and
10) protection of agricultural plants, particularly agricul-
tural plants in which the revenue-producing product is
located above-ground, such as fruits, vine-vegetables,
beans and peas, and leaf vegetables.
In one particular embodiment, an extract according to the
present disclosure, particularly an A. ferroxidans extract,
may be applied to a fruit or vegetable, such as a watermelon
or a tomato, during at least a part of its growth to increase
the amounts of one or more nutrients of the fruit or veg-
etable, such as a vitamin, mineral, or other recommended
dietary component. In one specific example, the amount of
lycopene may be increased (which may be accompanied by
a decrease in carotene or other less-valuable nutrients
formed by competing pathways). In another specific
embodiment, the amount of a flavor-enhancing component,
such as glucose, may be increased. In another specific
embodiment, a component beneficial to the plant may be
increased. For example, an increase in glucose helps protect
against water loss.
The extract may be applied for approximately 25%, 50%,
75%, 90% or 99% of the fruit or vegetable's on-plant life,
where the on-plant life includes the time span from the
formation of a separate body that will constitute the fruit or
vegetable (excepting flowers) until the fruit or vegetable is
harvested. In a specific embodiment, the extract may be first
applied when the fruit or vegetable is sufficiently large to no
longer be substantially protected from UV radiation by
leaves. In another specific embodiment, the extract may first
be applied five days, one week, or two weeks prior to
harvest. This embodiment may be particularly useful with
fruits or vegetables in which an increase in a nutrient or
flavor-enhancing component may be obtained by protecting
the fruit or vegetable from UV radiation later in its on-plant
life.
The extract may be applied once or multiple times to each
fruit or vegetable. For example, it may be applied weekly, or
it may be reapplied after the fruit or vegetable is exposed to
rain or after a turning process.
6
Application may be accomplished with a commercial
sprayer. Application may be only one the upper portions of
the fruit or vegetable, which are exposed to substantially
greater amounts of UV radiation than lower portions of the
5 fruit or vegetable.
UV-Resistant Microbes
According to another embodiment, a yeast or bacteria,
particularly a beneficial yeast or bacteria such as one used in
a fermentation process, may be engineered to be UV-
10 
resistant by transforming or transfecting the yeast or bacteria
with a nucleic acid able to express a protein up-regulated by
UV-exposure or with a nucleic acid able to ultimately cause
a decrease in expression of a protein down-regulated by
15 UV-exposure. These nucleic acids may be under the control
of a constitutive promoter or under control of a UV-induc-
ible promoter. Particularly in embodiments in which the
yeast or bacteria needs to perform another function, such as
fermentation, the nucleic acids may be under control of
20 UV-inducible promoter so as not to impeded the other
function when UV protection is not required.
In one specific embodiment, a yeast may be transfected
with a nucleic acid encoding at least one of the following: a
Msn4pn, a ruvB, a heat shock protein, such as a heat shock
25 protein SSB1, an alcohol dehydrogenase (ADH) protein, a
NADH-cytochrome b5 reductase 2, a NADP-specific gluta-
mate dehydrogenase, a superoxide dismutase, a hexokinase
protein, such as hexokinase 1, or a phosphate glycerate
mutase. In another embodiment, a bacterium may be trans-
30 formed with a nucleic acid encoding at least one of the
following: a major outer membrane protein, such as major
outer membrane protein 40, a RuBisCO large subunit 1 or 2,
a phosphoribulokinase, a Ketol-acid reductoisomerase, a
pyridine nucleotide-disulfide oxoreductase, a methionine
35 synthase, or a methyltransferase.
Methods Using UV-Resistant Microbes
UV-resistant microbes may be used in fermentation pro-
cesses, such as in the production of alcohol or fuel ethanol,
or in the production of chemical and pharmaceutical prod-
40 ucts, including biological drug products.
EXAMPLES
The present disclosure may be better understood through
45 reference to the following examples. These examples are
included to describe exemplary embodiments only and
should not be interpreted to encompass the entire breadth of
the invention.
50 Example 1: Bacteria Culture and UV Exposure
A. ferroxidans (ATCC 13598) was grown in ATCC liquid
medium #2039 Brown, following the ATCC recommenda-
tions. ATCC liquid medium #2039 Brown contains different
55 ingredients including minerals salts such as Fe (II or III), Mg
(II), Zn (11), Mn (11), Ca (11), Co (II), Cu (11), and other
solutions such as NaC12, Nitrilotriacetico acid, (NH4)2SO4,
A1K(SO4)2, H,130, Na2MoO4. The medium was prepared
based on 1 liter volume. Fifty mL of A. ferroxidans stock
60 culture (1 month old) was transferred into 5 liters of ATCC
liquid medium #2039, as above described, in a 6 liter flask.
Two types of media were prepared, one containing Fe (II)
and the other containing Fe (III), in addition to the other
ingredients, as mentioned above. The flasks containing the
65 A. ferroxidans cultures were covered with a spongy stopper,
thus allowing oxygen penetration, and incubated at room
temperature for 12 days.
US 9,987,219 B2
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After 12 days of incubation, two liters of A. ferroxidans
cultures were transferred into OJO-sterilized glass trays (200
mL per each tray), aseptically. The trays containing the A.
ferroxidans cultures were exposed to UV radiation at a short
wavelength, 254 nm or a long wavelength, 365 nm for 0, 12,
24, 48, 72, 96 or 120 hours. Different trays were used per
different type of iron (Fe II or Fe III) and for different lengths
of time, as above described. Only two trays containing the
A. ferroxidans cultures were used at a time. An ultraviolet
fluorescent analysis cabinet (50 cmx50 cmx20 cm) (Spec-
troline model cc-80) was used for the UV irradiation.
TABLE 1 indicates the effect of the short wave UV
irradiation (254 nm) on growth of the bacterium A ferroxi-
dans. The results show that growth of the bacterium A
ferroxidans was not significantly affected by the UV radia-
tion, even after 48 hours of exposure. In fact, the biomass of
A. ferroxidans, although showing an initial decrease,
rebounded and was not significantly decreased as compared
to the initial biomass after 24 hours of exposure to UV
radiation. This biphasic growth is a typical growth pattern
for A. ferroxidans. When growth is slower new medium and
additional oxygen is typically required for growth to con-
tinue. The overall higher levels of biomass at 0.5 and 48
hours in the UV-exposed bacteria as compared to non-UV-
exposed bacteria shows that the UV light can in fact provide
additional energy to the fermentation process, allowing the
bacteria to grow without the need for new medium or
additional oxygen, or with less frequent addition of new
medium or additional oxygen.
TABLE 1
Growth of Bacterium A. Ferroxidans (ATCC 13598)
Under Exposure to UV Irradiation for Up To 2 Days
Length of Bacterial Growth (biomass mg/L)'
Exposure No-UV (Control) UVI
(Hour) Trials' Average Trials Average
0 250 + 250 + 250 250 250 + 250 + 250 250
0.5 100 + 50 + 100 83 250 + 100 + 250 200
24 125 + 100 + 350 255 250 + 125 + 250 245
48 5 + 5 + 130 13 20 + 100 + 250 155
'Three different trials were carried out.
2A 254 nm T, UV radiation source was used.
'The weight (mg/L) was obtained as a pellet from the bacterium.
Example 2: Extract Preparation
After the relevant period of time for each sample, the A.
ferroxidans culture samples exposed to UV radiation were
taken and subjected to centrifugation at approximately
10,000xg (13,000 RPM) for 5 minutes at 4° C. The cen-
trifugation process was repeated three times for each sample.
The supernatant was discharged and the pellet was saved to
be used immediately; otherwise, the pellet was kept at —25°
C., until use.
The pellet was dried under vacuum in a lyophilizer at
—40° C. and pulverized. The pulverized pellet was mixed
with sterilized de-ionized water in order to obtain different
concentrations of pellet material (0.05 g/mL, 0.10 g/mL,
0.15 g/mL, 0.20 g/mL, and 0.25 g/mL). 0.25 g/mL or higher
concentrations of the extract may be preferable because
more extract material generally provides a greater protective
effect. However, increases in protective effect may be neg-
ligible in some uses above certain concentrations. Further,
8
smaller concentrations may be desirable in some uses,
particularly if the extract has negative side-effects in that
use.
5
Example 3: UV Protection Testing
UV radiation is know to kill prokaryotic and simple
eukaryotic cells. Accordingly, a decrease in cell death for
io these cells when exposed to UV radiation in the presence of
a material indicates that the material is a UV protectant and
blocks UV radiation. Cell death tests were performed using
prokaryotic cells such as Bacillus subtilis (wild type isolated
from the Prairie View A&M University farm), Staphylococ-
15 cus aureus (ATCC 6538), Salmonella typhimurum (ATCC
14028), and eukaryote cells such as Saccharomyces cerevi-
siae (ATCC 66348).
The bacterial cells were grown in nutrient broth and/or
nutrient agar plates (Difco, Detroit, Mich.) and the yeast
20 cells were grown in yeast extract nutrient broth and/or agar
plates. The microbial cultures were incubated at 30° C., and
used after 24 hours for bacteria and after 48 hours for yeast.
Microbial cells were used during exponential growth, and
their population was measured by optical density reading
25 (O.D.) at 600 nun. Different O.D. were used (0.3, 0.5, 0.8,
and 1.0), however, 0.5 was preferred because cells were in
exponential growth at this OD and not near the end of it.
From each bacterial solution, different fresh dilutions (10,
30 100, 1,000, 10,000, and 1,000,000 cells/mL) were prepared,
but 10,000 cells/mL dilution was preferred because it
assured sufficient cell density, but did not reach non-expo-
nential growth stages too early. Twenty mL from each
dilution were separately transferred to sterile 9 cm Petri
35 plates. Three replicates for each bacterial or yeast dilution
were exposed to shortwave (254 mu) or longwave (350 mu)
UV radiation for different lengths of time (15, 30 or 60
minutes). However, bacterial or yeast exposure to shortwave
UV radiation for 60 minutes was preferred because it
40 represents harsher conditions that longwave radiation and
shorter time periods. Shortwave UV radiation is known to be
more lethal to most organisms than longwave UV radiation.
Bacterial or yeast cultures were exposed alone (control) or
in mixture with the pulverized A. ferroxidans pellet extract
45 from Example 2 (treatment). Different concentrations of the
extract (0, 150, 200, or 250 mg/mL) were used. However,
250 mg/mL was preferred and was used to obtain the data
presented in TABLES 2-4. The mixture was always well
stirred in order to ensure complete mixing of the bacterial or
50 
yeast cells with the extract. In addition to control (bacteria
or yeast alone), different types of extract treatments were
used:
1) Bacillus subtilis (wild type)
2) B. subtilis+Extract of A. ferroxidans (from 4-week-old
55 culture)
3) B. subtilis+Extract of A. ferroxidans (from 2-week-old
culture)
4) Salmonellas typhimurum (ATCC 14028)
60 5) S. typhimurum (ATCC 14028)+Extract of A. ferroxidans
(from 4 week-old culture)
6) S. typhimurum ATCC 14028+Extract of A. ferroxidans
(from 2 week-old culture)
65 7) Staphylococcus aureus (ATCC 6538)
8) S. aureus (ATCC 6538)+Extract of A. ferroxidans (from
4-week-old culture)
US 9,987,219 B2
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9) S. aureus (ATCC 6538)+Extract of A. ferroxidans (from
2-week-old culture)
10) Saccharomyces cerevisiae (ATCC 66348)
11) S. cerevisiae (ATCC 66348)+Extract of A. ferroxidans
(from 4 week-old culture)
12) S. cerevisiae (ATCC 66348)+Extract of A. ferroxidans
(from 2 week-old culture)
13) C. albicans
14) C. albicans+Extract of A. ferroxidans
After exposure of the liquid microbial cultures to UV
irradiation, 1 mL of the UV-irradiated microbial dilutions
(10,000 cells/mL) was placed into the center of a sterile Petri
dish, and agar media (nutrient agar for bacterial cultures or
yeast extract agar for yeast) was poured into the Petri dish,
thus following the standard pour plates technique. Two
different size of Petri dishes were used: 1) standard plain 9
cm diameter, and 2) a 9 cm diameter Petri dish divided into
three equal areas. A minimum of six replicates per dilution
were made. The microbial cultures were immediately incu-
bated at 30° C. Microbial growth was determined and
counted after 24, 48, 60, and 72 hours and after one week.
Microbial growth was determined by using the standard
counting of the number of colony forming units (CFU) of the
UV-irradiated or non-irradiated microbial cultures.
The results as indicated in TABLES 2-4 clearly demon-
strate the UV protection that A. ferroxidans extract provides
to S. cerevisiae, C. albicans, and B. subtilis. Similar results
were obtained using the other organisms in the list above.
TABLE 2 shows prolific growth of S. cerevisiae in all the
plates with yeast culture that were also previously treated
with the extract of A. ferroxidans, and exposed to UV
radiation for 1 hour, and later incubated at 30° C. for 72
hours. All plates were fully covered by the yeast. In contrast,
yeast cultures that were not treated with the extract of A.
ferroxidans did not show substantial growth at all, thus
indicating that the cells were not protected from the UV
radiation and were killed. This indicates that the extract of
A. ferroxidans is able to protect eukaryote cells such as yeast
cells from UV damage. Therefore, the extract of A. ferroxi-
dans should be effective to protect other eukaryote cells such
as mammalian cells against UV radiation.
10
growth at all. This corroborates the protective effect of the
A. ferroxidans extract against UV radiation in a different
eukaryotic cell, C. albicans.
5 TABLE 3
Protection Against UV Radiation by A. Ferroxidans
Extract in Cultures of C. 41bicans
Colony Count
10
Treatment Plate 1 Plate 2 Plate 3 Mean STDEV
CA' only (control) 103 91 89 94.33 7.57
CA + UV 0 0 0 0.00 0.00
CA + EAF2 101 94 104 99.67 5.13
15 CA + EAF + UV 92 107 82 93.67 12.58
'CA = Candida albicans.
2EAF = Extract from Aeidithiobaedlus ferroxidans
TABLE 4 shows the marked protective effect of A.
20 ferroxidans extract against UV radiation in a prokaryote cell
such as Bacillus subtilis. The results show great growth of
the bacterium fully covering the plates in those cultures
treated with the A. ferroxidans extract, as compared to those
plates that were not treated and which showed no bacterial
25 growth. All plates were exposed to UV irradiation for 1 hour
and then incubated without UV radiation for 72 hours. These
results indicate the efficacy of A. ferroxidans extract in
protecting bacterial cells as well.
30 TABLE 4
Protection Against UV Radiation by A. Ferroxidans
Extract in Cultures of B. Subtilis
Colony Count
35
Treatment Plate 1 Plate 2 Plate 3 Mean STDEV
BS only (control) FC' FC FC N/A N/A
BS2 + UV 0 2 0 0.67 1.15
BS + EAF' FC FC FC N/A N/A
40 BS + EAF + UV FC FC FC N/A N/A
'FC = AGAR Plates fully covered.
2 13 = Bacillus subtilis.
'EAF = Extract from Aeidithiobaedlus ferroxidans.
TABLE 2 45
Example 4: Effects of UV Protective Agent on S.
Protection Against UV Radiation by A. Ferroxidans Cerevisiae Stress Response Gene Expression
Extract in Cultures of S Cerevisiae
Colony Count
Treatment Plate 1 Plate 2 Plate 3 Mean STDEV
SAC' only (control) FC' FC FC N/A N/A
Sac + UV 0 0 1 0.33 0.58
SAC + EAF2 FC FC FC N/A N/A
SAC + EAF + UV FC FC FC N/A N/A
'FC = Agar plates fully covered by microbial growth.
2EAF = Extract from Aeidithiobaedlus ferroxidans.
'SAC = Saccharomyces cerevisiae.
TABLE 3 and FIG. 4 show the protective effect A.
ferroxidans extract against UV radiation in a different yeast,
C. albicans. The A. ferroxidans extract gave full protection
to C. albicans growing at 30° C. for 72 hours. C. albicans
with A. ferroxidans extract was exposed to UV radiation for
1 hour, then incubated at 30° C. for 72 hours and no UV
radiation. The yeast grew as much (95-100%) as the non-UV
treated yeast cultures. However, all UV-treated cultures
without the protective A. ferroxidans extract showed no
The effects of the A. ferroxidans extract to protect yeast
50 against UV damage were further confirmed by evaluating
the expression of five genes, which encode zinc finger
proteins, known to be involved in chromosomes repair, after
exposure to damage by different stressing factors including
UV radiation. The genes were expressed in S. cerevisiae
55 (ATCC 66348). The semi-quantitative real time polymerase
chain reaction (qRT-PCR) was used for analysis.
S. cerevisiae previously treated with the A. ferroxidans
extract were grown for 2-4 days in liquid cultures at 26-30°
C. see as described above. Control cell were not treated with
60 the A. ferroxidans extract. Two hundred mL of yeast cultures
were grown in 500 ml flasks, each, under shaking conditions
(350 RPM). Six replicates were used for each yeast culture.
After 2-4 days incubation, cells were harvested and sub-
jected to centrifugation to obtain a pellet. Fifty mL of yeast
65 culture sample were used in four replicates each. Cells were
centrifuged three times at 15,000 RPM, under refrigeration
(4° C.) for 10 minutes three times. Cells were harvested as
US 9,987,219 B2
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pellets, and the pellets were kept under freezing conditions
(-80° C.) or used immediately for further analysis.
For each pellet, the quantity and quality of the total RNA
was determined by UV spectroscopy, using the a Nano-
DropTM spectrophotometer. cDNA was synthesized from
total RNA with a combination of random hexamers and
oligo dT and Superscript III®. cDNA was also synthesized
with oligo dT only and Superscript II®. After cDNA syn-
thesis, the RNA was digested with RNase H. SYBR green
was used for real time detection of the PCR products in the
7900HT Sequence Detection System.
PCR amplification primers were designed for each gene
of interest, as follows:
S.
cerevisiae Amplicon
gene primers (listed 5' to 3 1 ) Size
dnaX-F TGGAAGCTGAAGCCGGG 122
(SEQ ID NO. 1)
dnaX-R AGAAACAAGAGCAATTTTTCCCC
(SEQ ID NO. 2)
Msn4p-F CGAAAGTGGCGACTACAGGC 111
(SEQ ID NO. 3)
Msn4p-R ATATTCATTTGATGATGATGGAAAGATCG
(SEQ ID NO. 4)
recA-F TACGGATTTTTCTGGTGG 101
(SEQ ID NO. 5)
recA-R CTGCAACACCAAATTGGTCG
(SEQ ID NO. 6)
ruvB-F GCAGTTACGAGAACTGCGGC 91
(SEQ ID NO. 7)
ruvB-R CAACAAACCCTCCTTCAACCC
(SEQ ID NO. 8)
GAPDH-F AACACCCATGACGAACATTGG 81
(SEQ ID NO. 9)
GAPDH-R CAAAAGCACATTGACGCTGG
(SEQ ID NO. 10)
Conditions were developed for the amplification of each
target gene by RT-PCR using genomic DNA as a template.
The expression level of each gene including GAPDH was
determined from each sample in triplicate. A reference
standard curve for each gene was generated and each point
was measured in triplicate. Positive controls using genomic
DNA and negative controls with cDNA synthesis reactions
where the reverse transcriptase was omitted and water only
were included in assays. Samples were amplified in the
7900HT Sequence Detection System at 95° C. for 10 min.
followed by 50 cycles at 95° C. for 30 sec., 60° C. for 30
sec., and 72° C. for 30 sec. Fluorescence measures were
made at the end of each extension cycle. Following PCR
amplification, a melting curve analysis was performed by
heating the samples at 95° C. for 15 sec., and 95° C. at 1
C/min.
After PCR amplification and melting curve analysis, a Ct
value was calculated for each sample. The relative amount
of RNA was determined comparing the Ct value of the test
samples to the control sample after normalization with
GAPDH. Ct values for any given sample were only used if
their value fell within the standard curve for each gene.
Otherwise, the assay was repeated and the test sample (i.e.
cDNA) was diluted.
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Several methods were tested for isolating and purifying
total RNA from S. cerevisiae. These methods include the
RNAeasy Mini KitTM (Qiagen), TRI ReagentTM (Sigma),
Master Pure Complete DNA and RNA Purification KitTM
5 (Epicentre Biotechnologies Inc.), hot phenol: chloroform:
isoamyl (Sigma) and modifications of some of these proto-
cols. The following modified RNAeasyTM protocol was
successfully used to isolate total RNA from S. cerevisiae.
to 
Frozen cellular pellets were thawed, thoroughly mixed
with 2-3 volumes RNA ProtectTM (Qiagen) and incubated
for 10 min. at 23° C. Cells were centrifuged at 5,000xg for
10 min at 23° C. Supernatant was decanted and discarded.
15 
Cell pellets were resuspended in 200 ul 15 mg/mL lysozyme
and 1.5 mg/mL proteinase K in 10 mM TRIS-HC1 (pH 7.4)
and 1 mM EDTA. Cells were incubated for 10 min. at 23°
C. Seven hundred µL RLT buffer were added and mixed by
vortexing. Samples were sonicated for 1 min. Four hundred
20 
seventy µL ethanol were added and mixed by vortexing. The
solution was applied to a resin spin-column. The spin-
column was centrifuged at 8,000xg for 10 sec. at 23° C.
Flow-through was discarded, and the remaining solution
25 was added and centrifuged as above. Eighty µL of DNase
solution was applied (70 µL RDD buffer and 10 µL DNase)
to the spin-column and incubated for 15 min. at 23° C. Three
hundred and fifty µL RW1 buffer was applied to the spin-
30 column solution. The spin-column solution was centrifuged
at 8,000xg for 1 min. at 23° C. Flow-through was discarded.
Five hundred µL RW1 was applied to the spin-column. The
spin-column was centrifuged at 8,000xg for 1 min. at 23° C.
35 Flow-through was discarded. Use of the spin-column was
repeated. The spin-column was transferred into a new col-
lection tube and centrifuged at 8,000xg for 1 min. at 23° C.
The spin-column was transferred into a new collection tube.
40 Fifty µL of RNase-, DNase-free water was added to the
center of the spin-column and left at 23' C. for 1-2 min. The
spin-column was centrifuged at 8,000xg for 1 min. at 23° C.
The flow-through was saved, because it contained the RNA.
45 The quantity and quality of the RNA was evaluated by
absorbance spectroscopy and agarose gel electrophoresis.
After RNA was isolated from the cells, the samples were
analyzed for gene expression by RT-PCR, as described
above. cDNA was synthesized with oligo dT, as described
5o above. A Northern Blot showed that stress response genes
were not significantly up-regulated after UV exposure in S.
cerevisiae previously exposed to the A. ferroxidans extract.
No significant differences were seen in the total RNA for the
cells.
55 Differences in expression for Msn4pn and ruvB, which
are involved in chromosome repair after stress-related dam-
age, were observed between samples of S. cerevisiae treated
with the A. ferroxidans extract and those not treated after the
samples were exposed to UV radiation as described above.
60 Results of further experiments regarding stress-response
gene expression in S. cerevisiae are shown in TABLE 5. In
TABLE 5, "SA" designates control S. cerevisiae that were
not treated with bacterial extract and not exposed to UV
radiation. "S5" designates S. cerevisiae treated with bacte-
65 rial extract and exposed to UV radiation for 48 hours. "S6"
designates S. cerevisiae treated with bacterial extract and
exposed to UV radiation for 72 hours.
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TABLE 5
Stress-Response Gene Expression in S. cerevisiae
SA (1:50 cDNA) - 1
SA (1:50 cDNA) - 2
SA (1:50 cDNA) - 3
SA (1:50 cDNA) - Mean
SA (1:50 cDNA) -
Std. Dev.
SA (1:50 cDNA) -
Std. Error
S5 (1:50 cDNA) - 1
S5 (1:50 cDNA) - 2
S5 (1:50 cDNA) - 3
S5 (1:50 cDNA) - Mean
S5 (1:50 cDNA) -
Std. Dev.
S5 (1:50 cDNA) -
Std. Error
S6 (1:50 cDNA) - 1
S6 (1:50 cDNA) - 2
S6 (1:50 cDNA) - 3
S6 (1:50 cDNA) - Mean
S6 (1:50 cDNA) -
Std. Dev.
S6 (1:50 cDNA) -
Std. Error
S5 (1:5 cDNA) - 1
S5 (1:5 cDNA) - 2
S5 (1:5 cDNA) - 3
US 9,987,219 B2
Msn4p recA ruvB GAPDH 5
(Ct) (Ct) (Ct) (Ct)
35.015858 31.099762 34.97601 25.63601
34.556225 31.193922 34.43322 25.67667
34.61304 31.48071 33.99136 25.86641
34.7 31.3 34.5 25.7 
10
0.25 0.20 0.49 0.12
0.14 0.11 0.28 0.07
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trifugation at 4° C. at 1500 RPM for 5 minutes three times,
and the supernatants were discarded each time. One gram of
final pellets were stored at -80° C. until use, otherwise, the
pellets were used immediately. Two samples were used for
analysis by two-dimensional difference gel electrophoresis
(21) DIGE) and protein identification by liquid chromatog-
raphy tandem mass spectrometry (LC-MS/MS). Six proteins
with increased or decreased expression are identified in
TABLE 6.
TABLE 6
S. Cerevisiaea Proteins Up-Regulated
48.143795 36.857708 39.42146 33.32396
or Down-regulated by UV Exposure
38.14609 37.113995 40.3668 32.55367 15
39.83437 36.967648 39.43715 33.174426
42.0 37.0 39.7 33.0 Protein Accession # Change
5.35 0.13 0.54 0.41
Heat shock protein SSBI P10591.4 GE417149 Increased
3.09 0.07 0.31 0.24 Protein disulfide isomerase P17967.2 GE129732 Decreased
20 Alpha-glucosidase MAL12 P53341.1 GE1708906 Decreased
34.409473 31.552845 34.38703 25.48201 Methyl tetrahydropteroyl triglutamate P05694.4 GI:730018 Decreased
34.430233 31.288467 34.8099 25.45857 NADH-cytochrome b5 reductase 2 P36060.1 GE549725 Increased
35.021397 31.782907 34.67211 25.69369 NADP-specific glutamate P07262.2 GE2506355 Increased
34.6 31.5 34.6 25.5 dehydrogenase
0.35 0.25 0.22 0.13
Superoxide dismutase P00447.1 GE134681 Increased
25
0.20 0.14 0.12 0.07 Hexokinase 1 P04806 GE1170444 Increased
Fructose-bisphosphate aldolase P14540.3 GE113626 Decreased
38.55734 32.21721 37.2342 30.968388 Phosphate glycerate mutase P00950.3 GE548534 Increased
37.911972 32.550484 37.835094 30.854069 Glucokinase 1 P17709.1 GE123899 Decreased
3723461 33 667084 40 251022 30 989134
S5 (1:5 cDNA) - Mean 37.9 32.8 38.4 30.9 30
S5 (1:5 cDNA) - 0.66 0.76 1.60 0.07
Std. Dev.
S5 (1:5 cDNA) - 0.38 0.44 0.92 0.04 Example 6: Identification of Protein Expression
Std. Error Changes in A. ferroxidans in Response to UV
S6 (1:5 cDNA) - 1 35.528088 32.005764 35.446632 26.329565 Radiation
S6 (1:5 cDNA) - 2 35.120403 31.908882 36.131447 26.248236 35
S6 (1:5 cDNA) - 3 35.390247 31.86025 35.302666 26.37515
S6 (1:5 cDNA) - Mean 35.3 31.9 35.6 26.3 A culture of A. ferroxidans was exposed to UV radiation
S6 (1:5 cDNA) - 0.21 0.07 0.44 0.06 for 72 hours. Samples were taken and analyzed for protein
Std. Dev.
as described in Example 5. Results are presented in TABLES6 (1:5 cDNA) - 0.12 0.04 0.26 0.04
Std. Error 40 7.
TABLE 7
Example 5: Identification of Protein Expression
A. ferroxidans Proteins Up-Regulated
or Down-regulated by UV Exposure45
Changes in S. Cerevisiaea in Response to UV
Radiation Protein Accession # Change
Major outer membrane protein 40 CAA10107.1 Increased
Yeast cells were grown in yeast extract agar media at RuBisCO large subunit 1 POC916.1 Increased
RuBisCO large subunit 2 POC917.1 Increased
28-30° C., overnight, following microbiological standard 50 Phosphoribulokinase ACK78673.1 Increased
procedures. The best grown colonies were selected to make Ribosomal protein S2 ACK79803.1 Increased
culture dilutions, which were used as a source of inoculum Ketol-acid reductoisomerase 135EP52.1 Increased
in liquid culture. Different yeast dilutions were then made,
Pyridine nucleotide-disulfide ACK80497.1 Increased
Hsp20 ACK78444.1 Decreased
and their concentrations were measured according to the Methionine synthase 135ELU7.1 Increased
absorbance (optical density-0.D) at 550-600 nun wave- 55 Serine hydroxymethyltransferase ACK78912.1 Increased
length). Different dilutions were used: 0.05, 0.02, 0.01, Chaperonin ACK77997.1 DecreasedHSP70 135ENA3.1 Decreased
0.0005 O.D. However, dilution 0.01 O.D was preferable.
Yeast cultures were then exposed to UV radiation for 48
hours an incubated at 28° C., then samples were taken to 60
determine protein expression. Samples were taken and Example 7: Identification of cDNA Changes in A.
mixed with phosphate buffer saline solution (PBS), pH 7.4 ferroxidans in Response to UV Radiation
following standard procedures (Sambrook, F., and Maniatis.
1989. Molecular cloning: A laboratory manual. 2nd edition, A culture of A. ferroxidans was exposed to UV radiation
Cold Spring Harbor Laboratory Press. Cold Spring Harbor, 65 for 72 hours. Samples were centrifuged to prepare pellets,
N.Y. Volume 3, appendix B, 12; Medicago AB. 2009.) The which were frozen. Pellets were subject to Real Time PCR.
mixture of yeast culture and PBS were subjected to cen- Primers and genes thus identified were as follows:
US 9,987,219 B2
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Amplicon
Gene Size Forward primer (5'-3 1 ) Reverse Primer (5'-3 1 )
ccbL2
(POC917. 1)
cbbP
(ACK78673.1)
rpsB
(ACK79803.1)
AFE_2086
(CK78444.1)
metE
(B5ELU7.1)
glyA
(ACK78912.1)
groES
(ACK77997.1)
dnaK
(B5ENA3.1)
gap
(ACK78716.1)
rpoC
(ACK80911.1)
117 GCCGGAAGCTGGGATGCACA
(SEQ ID No. 11)
94 CAGCGCACCTGGCACCTTCA
(SEQ ID No. 13)
100 CACGGCGCTCAGCTTTGTCG
(SEQ ID No. 15)
126 CCCCTGGATGGTAAGCACCC
CT (SEQ ID No. 17)
158 TGGTGGGGAAGGCAGGCAG
T (SEQ ID No. 19)
71 GGACCGTGCGCTGGAGCTTT
(SEQ ID No. 21)
83 ATGGCCGGCAGCGACGATTT
(SEQ ID No. 23)
138 GGCGCGGGTCAGCTTCATGT
(SEQ ID No. 25)
128 TTTCTTGGCGCCGCCCTTGA
(SEQ ID No. 27)
83 TGTCGCTGGAGGCGCAGTTG
(SEQ ID No. 29)
GAAGCGCACCGTGGCCTGAT
(SEQ ID No. 12)
GCCCGTCTTCACGCCACCAT
(SEQ ID No. 14)
AGCTTCCTGCTCGACGGCCT
(SEQ ID No. 16)
GATTGGTCGCCCCGCGTTGA
(SEQ ID No. 18)
AGCCGTCGCCTCACGCAAAA
(SEQ ID No. 20)
GATTGGCCTGCGAGCCGGAA
(SEQ ID No. 22)
AGCAGAAGACTGCCGGTGG
GA (SEQ ID No. 24)
GCCATGCAGCGCCTGAAGGA
(SEQ ID No. 26)
TGCTTGCCGAACGCGATCCT
(SEQ ID No. 28)
AACGGGCTCACCATTGGCCG
(SEQ ID No. 30)
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cDNA levels for ccbL2 (ribulose bisphosphate carboxy- 30 TABLE 8-continued
lase, large subunit 2, abbreviated RuBisCO summit 2) and
metE (methyltransferase), increased by 20% following UV- Growth Markers in UV-Resistant S. Cerevisiaea
exposure. cDNA levels for dnak (chaperone protein Dnak), DNA RNA ATP
glyA (serine hydromethyltransferase) and rpsB (ribosomal Sample Uv OD (ng/µL)* (ng/µl)* (RLU
protein s2) decreased by between 60% and 70%. 35 3 genes- y 1.217 85.5 1.2 60.8 3.1 89 17
3genes- N 0.571 19.7±1.5 5.5±1.2 97±12
Example 8: Transfection of S. Cerevisiaea to HSP70 y 1.119 98.5 0.2 117.2 2.3 105 13
Increase UV-Resistance HSP70 N 0.564 9.7 0.85 15.8 .92 120 17
ADH Y 1.109 126±5.1 110.2±3.1 121±14
S. Cerevisiaea were transfected with the plasmid shown in 40 ADH N 0.601 5.7 1.2 24.5 0.5 155 12
FIG. 1 (3 genes), with a similar plasmid containing only Hexokinase Y 1.098 84 ± 4.2 80.5 ± 1.5 81 ± 22Hexokinase N 0.519 7.2 1 7.8 1.15 57 ± 11
HSP70, ADH, or hesokinase, or with an identical plasmid Control y 0.532 80.2 2.5 42.3 1.4 87.9 ± 12.1
lacking the riboswitch component (3 genes-). Transfected Control N 0.435 8.9 1.4 14.3 1.7 102 ± 15
yeast cells were grown in yeast extract agar plates at 28-30°
45
C., overnight. Culture solutions were made and inoculated
*Mean +/- standard deviation
into 250 ml yeast extract liquid media contained in a 1 liter
oD opbeai density;
ATP Adenosine triphosphate;
sterile glass bowl. Thus, the initial working concentration of RLU Relative inaineseenee units
the yeast cells cultures were equivalent to an optical density
(O.D) of 0.07 at 600 mu. pH of cultures were adjusted to 
50
4-4.5; the experiments were set up in triplicates. The yeast Example 9: Fermentation Using UV-Resistant S.
cultures were incubated under alternate regimes of 12 hours Cerevisiaea
of no-UV radiation and 48 hours of UV-radiation (254 mu),
and continued shake (300 RPM), a total of 60 hours incu-
bation at 28-30o C. Incubation was completely covered and
55
S. Cerevisiaea were transfected with the plasmid similar
protected against any kind of light from outside. Markers of to that of FIG. 1, containing only HSP. Yeast were cultured
cell growth were measured and results are reported in and then exposed to UV radiation for 48 hours. Fermentation
TABLE 8. Control yeast were not transfected. products in the yeast were then measured using HPLC.
Results for glucose production are shown in TABLE 9.
TABLE 8
Growth Markers in UV-Resistant S Cerevisiaea
DNA RNA ATP
Sample UV OD (ng/µL)* (ng/pl)* (RLII)
60
3 genes Y 1.108 154 ± 8.2 120.9 ± 6.8 93 ± 9 65
3 genes N 0.580 53.5 ± 2.8 19.4 ± 1.1 115 ± 20
TABLE 9
Glucose Production in UV-Resistant S. Cerevisiaea
Sample UV Glucose (g/L)
HSP + Yeast Y 63.92 +/- 7.92
HSP + Yeast N 606.32 +/- 72.10
US 9,987,219 B2
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TABLE 9-continued
Glucose Production in UV-Resistant S. Cerevisiaea
Sample UV Glucose (g/L)
Control Y 0
Control N 0
Increased inositol production was also observed.
Example 10: Protection of Watermelons from UV
Damage by A. ferroxidans Extract
An extract was prepared from an A. ferroxidans culture
previously exposed to UV-radiation for 72 hours. Sans
Pepins wateremelon fruits were cleaned in sterile water and
dried with a paper towel. The watermelons were then coated
with different concentrations of bacterial extract (0.1, 0.2,
0.5, 0.7 and 1%) using a small brush or by spraying until
their entire surfaces were covered. Watermelons were then
placed in a Percival environmentally-controlled chamber
(Percival Scientific, Perry, Iowa) and exposed to 254 nm or
360 nm UV radiation at a temperature of 27-29° C. and 85%
relative humidity for two weeks. Control watermelons
coated with water were also tested.
Watermelons were assed for color and shape of the fruit
rind, blistering of the watermelon fruit, color and ripening
(texture) of the flesh of the fruit, and content of glucose,
carotene, and lycopene.
Flesh color was assigned the following values: 1—pale,
2—pale red, 3=medium red, 4—dark red.
Firmness (textures) was assigned the following values:
1=hard, 2=medium hard, 3=soft, 4—very soft.
Blistering was assigned the following values: 0%=no
blistering, 1=10%blistering, 2=25%blistering, 3=50%blis-
tering, 4=75-100% blistering.
Rind color was assigned the following values: I—very dull
green, 2—dull light green, 3=medium green, 4—very (bright)
green
Glucose, carotene, and lycopene content were determined
using HPLC.
Results are presented in TABLES 10 and 11.
11OHMMI
Effects of Extract on Watermelon Color, Blistering,
Flesh Color. and Flesh Texture
Sample Rind Color Blistering Flesh Color Flesh Texture
Extract + UV 4 0 3 3
Water + UV 2 2 2 4
TABLE 11
Effects of Extract on Watermelon Glucose,
Lycopene, and Carotene Content
Sample Glucose (g/L) Carotene (mg/L) Lycopene (mg/kg)
Extract + UV 13.00 +/0.90 20.40 +/— 1.64 47.87 +/— 5.14
Water + UV 12.07 +/— 0.75 45.17 +/— 7.73 27.07 +/— 3.64
Example 11: Protection of Fibroblasts from UV
Damage by S. Cerevisiaea Extract
S. Cerevisiae cells were transfected with the plasmid of
FIG. 1. Extracts of these yeast were applied to fibroblast
18
cultures (which are indicative of skin protection), which
were then exposed to UV radiation. Fibroblast cells were
then stained for indicators of apoptosis (staining method
differentiates between live and dead cells) and cell numbers
5 were counted using microscopy. Control samples were not
treated or were treated with extract from non-transfected
yeast. Results are presented in TABLE 12.
TABLE 12
10
Effects of Extract on Fibroblast Resistance to UV-Radiation
Sample UV % Apoptosis Cell count
Fibroblasts N 0 15 alive, 1 dead
15 Fibroblasts Y 78.7 18 alive, 7 dead
Fibroblasts + Transfected Y 0 18 alive, 2 dead
Extract
Fibroblasts + Non-transfected Y 0 17 alive, 4 dead
Extract
20
Example 12: Solubility and Toxicity Data
Extracts from S. Cerevisiae and A. ferroxidans were tested
to determine their solubility in water and their toxicity.
25 Results are presented in TABLE 13.
TABLE 13
Solubility and Toxicity Data
30
Solubility Toxicity
Extract mg/ml (LDso) mg/Kg
S. ceresiviae + no UV 0.05 88.3-100
S. ceresiviae + UV 0.015 100
35 
A. ferroxidans + UV 0.15 100
Water solubility may be important for various reasons
depending on the use. For example, in methods where the
extract is applied to a fruit or vegetable, good water solu-
4o bility means that the extract should be largely removed when
the fruit or vegetable is washed, decreasing the risk of any
safety hazards for consumers. Good water solubility also
indicates that keeping the extract in solution and thereby
benefiting from its protective effects during a fermentation
45 process may be easier.
Toxicity is significant because it indicates the likelihood
of any adverse effects from the extracts if they are con-
sumed. A high LDso value indicates that more of the extract
may be consumed without adverse effects. In general, the
50 extract may be used so that the amount present on a fruit or
vegetable or in portion of a fermentation product typically
consumed is less than the LDso•
Although only exemplary embodiments of the invention
are specifically described above, it will be appreciated that
55 modifications and variations of these examples are possible
without departing from the spirit and intended scope of the
invention. For example, throughout the specification par-
ticular measurements are given. It would be understood by
one of ordinary skill in the art that in many instances
60 particularly outside of the examples other values similar to,
but not exactly the same as the given measurements may be
equivalent and may also be encompassed by the present
invention. As another example, although only monocultures
of particular microbes are described herein for extract pro-
65 duction, it will be understood that co-cultures are possible
and may provide the benefit of different sources of UV-
blocking components in the same extract.
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SEQUENCE LISTING
<160> NUMBER OF SEQ ID NOS: 30
<210> SEQ ID NO 1
<211> LENGTH: 17
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 1
tggaagctga agccggg 17
<210> SEQ ID NO 2
<211> LENGTH: 23
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 2
agaaacaaga gcaatttttc ccc 23
<210> SEQ ID NO 3
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 3
cgaaagtggc gactacaggc 20
<210> SEQ ID NO 4
<211> LENGTH: 29
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 4
atattcattt gatgatgatg gaaagatcg 29
<210> SEQ ID NO 5
<211> LENGTH: 18
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 5
tacggatttt tctggtgg 18
<210> SEQ ID NO 6
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 6
ctgcaacacc aaattggtcg 20
<210> SEQ ID NO 7
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
20
21
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<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 7
gcagttacga gaactgcggc 20
<210> SEQ ID NO 8
<211> LENGTH: 21
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 8
caacaaaccc tccttcaacc c 21
<210> SEQ ID NO 9
<211> LENGTH: 21
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 9
aacacccatg acgaacattg g 21
<210> SEQ ID NO 10
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 10
caaaagcaca ttgacgctgg 20
<210> SEQ ID NO 11
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 11
gccggaagct gggatgcaca 20
<210> SEQ ID NO 12
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 12
gaagcgcacc gtggcctgat 20
<210> SEQ ID NO 13
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 13
cagcgcacct ggcaccttca 20
22
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-continued
<210> SEQ ID NO 14
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 14
gcccgtcttc acgccaccat 20
<210> SEQ ID NO 15
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 15
cacggcgctc agctttgtcg 20
<210> SEQ ID NO 16
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 16
agcttcctgc tcgacggcct 20
<210> SEQ ID NO 17
<211> LENGTH: 22
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 17
cccctggatg gtaagcaccc ct 22
<210> SEQ ID NO 18
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 18
gattggtcgc cccgcgttga 20
<210> SEQ ID NO 19
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 19
tggtggggaa ggcaggcagt 20
<210> SEQ ID NO 20
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
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<400> SEQUENCE: 20
agccgtcgcc tcacgcaaaa
<210> SEQ ID NO 21
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
20
<400> SEQUENCE: 21
ggaccgtgcg ctggagcttt 20
<210> SEQ ID NO 22
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 22
gattggcctg cgagccggaa 20
<210> SEQ ID NO 23
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 23
atggccggca gcgacgattt 20
<210> SEQ ID NO 24
<211> LENGTH: 21
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 24
agcagaagac tgccggtggg a 21
<210> SEQ ID NO 25
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 25
ggcgcgggtc agcttcatgt 20
<210> SEQ ID NO 26
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 26
gccatgcagc gcctgaagga
<210> SEQ ID NO 27
20
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<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 27
tttcttggcg ccgcccttga 20
<210> SEQ ID NO 28
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 28
tgcttgccga acgcgatcct 20
<210> SEQ ID NO 29
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 29
tgtcgctgga ggcgcagttg 20
<210> SEQ ID NO 30
<211> LENGTH: 20
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic primer
<400> SEQUENCE: 30
aacgggctca ccattggccg 20
40
The invention claimed is: ing to culture the yeast subsequent to exposing it to UV
1. A method of preparing a UV-blocking composition radiation and prior to extracting.
comprising: 6. The method of claim 1, wherein extracting comprises
exposing a culture of yeast transfected with a nucleic acid 45 pelletizing the culture of yeast in a centrifuge to form an
encoding at least the following proteins in the follow- extract pellet.
ing order: a heat shock protein, an alcohol dehydroge- 7. The method of claim 1, wherein extracting comprises
nase protein and a hexokinase protein to UV radiation evaporating a culture medium containing the culture of
for a length of time sufficient to induce production of a yeast.
UV-blocking cellular material in the yeast in response 50 8. The method of claim 1, wherein extracting comprises
to the UV radiation; and extracting UV-blocking cel- isolating a protein from the culture of yeast.
lular material comprising protein produced in response 9. The method of claim 1, further comprising forming a
to the UV radiation from the yeast, wherein the nucleic composition comprising the UV-blocking cellular material
acid encoding the proteins is under control of a pro- in a concentration between approximately 0.05 g/mL and
moter. 55 0.025 g/mL.
2. The method of claim 1, wherein the yeast comprises S. 10. The method of claim 1, further comprising formulat-
Cerevisiaea. ing the UV-blocking cellular material in a carrier to form a
3. The method of claim 1, wherein extracting comprises composition.
centrifuging the yeast culture under conditions sufficient to 11. The method of claim 1, wherein the UV-blocking
precipitate UV-blocking cellular proteins. 60 composition blocks at least approximately 50% of UV
4. The method of claim 1, wherein the UV radiation radiation.
comprises short wave UV radiation, long wave radiation, or 12. The method of claim 1, wherein the UV-blocking
a combination of both. composition blocks at least approximately 50% of longwave
5. The method of claim 1, wherein exposing the culture of UV radiation.
yeast to UV radiation is for a time not sufficient to substan- 65 13. The method of claim 1, wherein the UV-blocking
tially kill the yeast in the culture and the method further composition blocks at least approximately 50% of short-
comprises ceasing exposure to UV radiation, then continu- wave UV radiation.
US 9,987,219 B2
29 30
14. The method of claim 1, wherein the transfected
nucleic acid further includes a riboswitch that at least
partially controls the expression of the encoded proteins.
15. The method of claim 1, wherein the nucleic acid
further encodes at least one of the following proteins: a 5
Msn4pn, a ruvB, a NADH-cytochrome b5 reductase 2, a
NADP-specific glutamate dehydrogenase, a superoxide dis-
mutase, or a phosphate glycerate.
16. The method of claim 1, wherein at least one heat shock
protein is heat shock protein SSBI. io
17. The method of claim 1, wherein at least one hexoki-
nase protein comprises hexokinase 1.
